Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement

1992 ◽  
Vol 67 (01) ◽  
pp. 08-12 ◽  
Author(s):  
Anthonie W A Lensing ◽  
Harry R Büller ◽  
Paolo prandoni ◽  
David Batchelor ◽  
Andre H M Molenaar ◽  
...  

SummaryTo determine whether the Rabinov-Paulin or the long-leg venography technique should be preferred in the diagnostic management of patients with clinically suspected deep-vein thrombosis, two independent experienced radiologists blindly assessed two different series of venograms of consecutive outpatients with clinically suspected deep-vein thrombosis. Venograms were obtained from two outpatient clinics of primary referral centres. In one centre the venograms were performed according to the technique of Rabinov and Paulin with the use of 100 ml of radiographic material and spot films of the calf, popliteal and more proximal veins. In the other centre, long-leg films were obtained after the administration of 150 ml of contrast material. The percentage venograms adjudicated as inadequate by at least one radiologist and inter-observer disagreement for both series were used as the main study outcome measures. Prior to the study, both radiologists agreed on the standardized criteria for a normal, abnormal and inadequate test result using a separate set of films.An inadequacy rate of 20% was found for the Rabinov-Paulin venography series (n = 123), whereas only 2% of the L26long-leg films were inadequate for interpretation (p <0.001). The interobserver disagreement for inadequacy, presence or absence of deep-vein thrombosis was 2I% for the Rabinov and Paulin venograms and 4o/" for the long-leg films (kappa, 0.65 and 0.92; 95% confidence intervals: 0.53 to 0.77 and 0.84 to 0.99, respectively; p <0.002).We conclude that the long-leg method is superior to the Rabinov-Paulin method in the venographic diagnosis of deep-vein thrombosis in symptomatic outpatients since noninterpretable test results are rarely observed and it reduces both unnecessary treatment of patients without deep-vein thrombosis and limits the undertreatment of patients with the disease.

Blood ◽  
2020 ◽  
Vol 135 (16) ◽  
pp. 1377-1385 ◽  
Author(s):  
Lisette F. van Dam ◽  
Charlotte E. A. Dronkers ◽  
Gargi Gautam ◽  
Åsa Eckerbom ◽  
Waleed Ghanima ◽  
...  

Abstract The diagnosis of recurrent ipsilateral deep vein thrombosis (DVT) is challenging, because persistent intravascular abnormalities after previous DVT often hinder a diagnosis by compression ultrasonography. Magnetic resonance direct thrombus imaging (MRDTI), a technique without intravenous contrast and with a 10-minute acquisition time, has been shown to accurately distinguish acute recurrent DVT from chronic thrombotic remains. We have evaluated the safety of MRDTI as the sole test for excluding recurrent ipsilateral DVT. The Theia Study was a prospective, international, multicenter, diagnostic management study involving patients with clinically suspected acute recurrent ipsilateral DVT. Treatment of the patients was managed according to the result of the MRDTI, performed within 24 hours of study inclusion. The primary outcome was the 3-month incidence of venous thromboembolism (VTE) after a MRDTI negative for DVT. The secondary outcome was the interobserver agreement on the MRDTI readings. An independent committee adjudicated all end points. Three hundred five patients were included. The baseline prevalence of recurrent DVT was 38%; superficial thrombophlebitis was diagnosed in 4.6%. The primary outcome occurred in 2 of 119 (1.7%; 95% confidence interval [CI], 0.20-5.9) patients with MRDTI negative for DVT and thrombophlebitis, who were not treated with any anticoagulant during follow-up; neither of these recurrences was fatal. The incidence of recurrent VTE in all patients with MRDTI negative for DVT was 1.1% (95% CI, 0.13%-3.8%). The agreement between initial local and post hoc central reading of the MRDTI images was excellent (κ statistic, 0.91). The incidence of VTE recurrence after negative MRDTI was low, and MRDTI proved to be a feasible and reproducible diagnostic test. This trial was registered at www.clinicaltrials.gov as #NCT02262052.


2007 ◽  
Vol 14 (3) ◽  
pp. 216-220 ◽  
Author(s):  
Simone Magazzini ◽  
Simone Vanni ◽  
Simone Toccafondi ◽  
Barbara Paladini ◽  
Maurizio Zanobetti ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (4) ◽  
pp. 623-627 ◽  
Author(s):  
Melanie Tan ◽  
Gerben C. Mol ◽  
Cornelis J. van Rooden ◽  
Frederikus A. Klok ◽  
Robin E. Westerbeek ◽  
...  

Key Points Diagnostic management of ipsilateral recurrent DVT of the leg is complicated because residual DVT is common and mimics acute DVT on CUS. MRDTI is able to reproducibly distinguish acute ipsilateral recurrent DVT from 6-month-old chronic residual thrombi in the leg veins.


Blood ◽  
1982 ◽  
Vol 59 (2) ◽  
pp. 346-350 ◽  
Author(s):  
A Zielinsky ◽  
J Hirsh ◽  
G Straumanis ◽  
CJ Carter ◽  
M Gent ◽  
...  

Abstract We have evaluated the fibrinogen/fibrin fragment E antigen assay as a diagnostic test in patients with clinically suspected venous thrombosis by comparing the results of this assay with venography in 272 patients. The result of the fragment E antigen assay was elevated in 79 of 80 patients with positive venograms for recent venous thrombosis (sensitivity 99%) and within the normal range in 161 of 192 patients with normal venograms (specificity 84%). The fragment E assay was also evaluated in 130 medical and surgical controls without evidence of venous thrombosis by leg scanning and the test was found to be relatively nonspecific. However, in the patient group under study, a correct clinical diagnosis of no thrombosis, based on a normal fragment E result, was made in 161 of 162 cases (negative predictive value of 99%). Therefore, a normal test result effectively excludes a diagnosis of venous thrombosis in clinically symptomatic patients. The assay, as currently performed, is technically demanding and takes 24 hr to complete. Therefore, it will have to be simplified before it can be applied to clinical practice.


2002 ◽  
Vol 162 (8) ◽  
pp. 907 ◽  
Author(s):  
Roderik A. Kraaijenhagen ◽  
Franco Piovella ◽  
Enrico Bernardi ◽  
Fabio Verlato ◽  
Erik A. M. Beckers ◽  
...  

Blood ◽  
1982 ◽  
Vol 59 (2) ◽  
pp. 346-350
Author(s):  
A Zielinsky ◽  
J Hirsh ◽  
G Straumanis ◽  
CJ Carter ◽  
M Gent ◽  
...  

We have evaluated the fibrinogen/fibrin fragment E antigen assay as a diagnostic test in patients with clinically suspected venous thrombosis by comparing the results of this assay with venography in 272 patients. The result of the fragment E antigen assay was elevated in 79 of 80 patients with positive venograms for recent venous thrombosis (sensitivity 99%) and within the normal range in 161 of 192 patients with normal venograms (specificity 84%). The fragment E assay was also evaluated in 130 medical and surgical controls without evidence of venous thrombosis by leg scanning and the test was found to be relatively nonspecific. However, in the patient group under study, a correct clinical diagnosis of no thrombosis, based on a normal fragment E result, was made in 161 of 162 cases (negative predictive value of 99%). Therefore, a normal test result effectively excludes a diagnosis of venous thrombosis in clinically symptomatic patients. The assay, as currently performed, is technically demanding and takes 24 hr to complete. Therefore, it will have to be simplified before it can be applied to clinical practice.


Sign in / Sign up

Export Citation Format

Share Document